Insider Selling: Danaher (NYSE:DHR) EVP Sells 1,320 Shares of Stock

Danaher Corporation (NYSE:DHR) EVP Gregory Milosevich sold 1,320 shares of Danaher stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the transaction, the executive vice president owned 5,099 shares in the company, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Danaher Price Performance

Shares of DHR stock traded down $1.69 on Friday, reaching $209.56. The company had a trading volume of 4,471,031 shares, compared to its average volume of 4,283,277. The business’s 50-day moving average is $227.19 and its 200 day moving average is $215.69. Danaher Corporation has a one year low of $171.00 and a one year high of $242.80. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35. The stock has a market capitalization of $148.02 billion, a PE ratio of 41.58, a price-to-earnings-growth ratio of 2.82 and a beta of 0.91.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The business had revenue of $6.84 billion during the quarter, compared to analysts’ expectations of $6.79 billion. During the same period in the prior year, the company earned $2.14 EPS. The firm’s quarterly revenue was up 4.6% compared to the same quarter last year. Equities research analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 30th. Investors of record on Friday, December 26th were issued a dividend of $0.32 per share. The ex-dividend date of this dividend was Friday, December 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is 25.40%.

Institutional Trading of Danaher

Several large investors have recently modified their holdings of the stock. Vanguard Group Inc. grew its holdings in Danaher by 1.3% in the second quarter. Vanguard Group Inc. now owns 60,769,587 shares of the conglomerate’s stock worth $12,004,424,000 after purchasing an additional 788,499 shares during the period. State Street Corp boosted its position in shares of Danaher by 1.7% during the 4th quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock worth $6,345,529,000 after purchasing an additional 472,608 shares in the last quarter. Capital International Investors grew its stake in shares of Danaher by 8.9% in the 4th quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock valued at $4,177,386,000 after buying an additional 1,487,768 shares during the period. Price T Rowe Associates Inc. MD increased its position in Danaher by 9.1% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock valued at $3,656,595,000 after buying an additional 1,334,221 shares in the last quarter. Finally, Wellington Management Group LLP raised its stake in Danaher by 11.2% during the 4th quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock worth $3,451,380,000 after buying an additional 1,517,904 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the company. Morgan Stanley started coverage on Danaher in a report on Monday, December 1st. They set an “overweight” rating and a $270.00 price target on the stock. TD Cowen reissued a “buy” rating on shares of Danaher in a report on Wednesday, January 7th. Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a research note on Saturday, November 22nd. The Goldman Sachs Group reduced their price objective on shares of Danaher from $270.00 to $265.00 and set a “buy” rating on the stock in a research note on Thursday, January 29th. Finally, Robert W. Baird set a $251.00 price objective on Danaher in a report on Thursday, January 29th. Twenty investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $253.86.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.